Trial Profile
Phase II study of sequential therapy with paclitaxel plus carboplatin followed by Gemzar [gemcitabine] plus carboplatin in the treatment of patients with epithelial ovarian cancer FIGO stages III-IV
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 25 Jun 2007
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Carboplatin; Paclitaxel
- Indications Ovarian cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly and Company
- 25 Jun 2007 New trial record.